[Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
D000172:Acromegaly / Q000097:blood* / Q000188:drug therapy; D000328:Adult; D000368:Aged; D001971:Bromocriptine / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology; D005260:Female; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D008090:Lisuride / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
D001971:Bromocriptine; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D008090:Lisuride; D004298:Dopamine
Vztah sekrece růstového hormonu ke zmĕnám tyreotropního hormonu po tyreoliberinu u nemocných s akromegalií a dopaminergní stimulace.